Goldman Sachs Knock-Out PGR/ DE000GG4YQE5 /
2024-04-30 10:58:48 AM | Chg.+0.04 | Bid11:24:33 AM | Ask11:24:33 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.44EUR | +2.86% | 1.43 Bid Size: 3,000 |
1.63 Ask Size: 1,000 |
Progressive Corporat... | 192.8477 USD | 2078-12-31 | Call |
GlobeNewswire
11:00 AM
CDR-Life Announces Fourth Milestone Achievement with Boehringer Ingelheim in Phase 1 Geographic Atro...
GlobeNewswire
04-29
ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 ...
GlobeNewswire
04-29
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate D...
GlobeNewswire
04-29
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegener...
GlobeNewswire
04-29
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Susp...
GlobeNewswire
04-25
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-22
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-22
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire
04-19
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire
04-18
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire
04-18
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
04-18
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
GlobeNewswire
04-18
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...
GlobeNewswire
04-17
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American ...
GlobeNewswire
04-16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-15
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatm...